The digital transformation of biomedical research must be deployed with full safeguards for patients

The creation of the European Health Data Space is emerging as a great opportunity to boost R&D for new medicines. Public-private collaboration, once again, at the heart of the advances that can be made in the expansion of precision medicine. Source: www.farmaindustria.es Research and development of new medicines is becoming increasingly open, collaborative and international. […]

Clinical trial succeeds in eliminating cancer in all participants

For the first time in the history of medicine a drug completely kills all patients’ tumours Source: www.larazon.es It’s called dostarlimab, it’s an experimental cancer drug, and it may be the beginning of a new era in the history of medicine. A clinical trial with the drug has successfully eliminated cancer in all 18 participants. […]

“Our code of conduct on data protection in clinical trials and pharmacovigilance is a benchmark for the future European code”.

Farmaindustria’s self-regulation document is the focus of a scientific meeting organised by the Royal National Academy of Pharmacy.   Source: www.farmaindustria.es Less than a month ago the Spanish Data Protection Agency (AEPD) approved the Code of Conduct regulating the processing of personal data in the field of clinical trials and other clinical research and pharmacovigilance […]

Hospital Puerta de Hierro joins a clinical trial that could change the paradigm of lung cancer

Source: www.immedicohospitalario.es The Hospital Universitario Puerta de Hierro Majadahonda, led by the Head of the Medical Oncology Department, Dr. Mariano Provencio, is participating in an international clinical trial whose results could mean a paradigm shift in the treatment of early and intermediate stage lung cancer. This clinical trial (Checkmate-816) is a multicentre, comparative study that […]

High intratumoural heterogeneity of endometrial cancer revealed

Source: www.immedicohospitalario.es Spanish researchers have just published a study that unravels the high intratumoural heterogeneity present in the different subtypes of endometrial cancer (serous and endometrioid) by analysing the exome of various regions of the primary tumour and its metastases. The study, published in ‘Oncogene’, has been carried out by the Autonomous University researchers Alba […]

CNIO, scientific leadership in oncology research

Source: www.immedicohospitalario.es It is among the top 10 cancer research centres in the world and among the top two in Europe. Since its creation in 1998, the Spanish National Cancer Research Centre (CNIO) has generated a legacy of research excellence, always with the aim of offering high-level scientific work and innovative technology, as well as […]

The new European harmonization of clinical trials, an opportunity to attract more investment to Spain

Since yesterday, the new Clinical Trials Information System (CTIS) has been operational, which centralizes processes with the aim of speeding up these studies Our country starts with an advantage, because it was the first to adopt European regulations and because of the coordinated work carried out by public and private agents, which has positioned us […]

Spain can benefit from the new European harmonization of clinical trials

The new Clinical Trials Information System (CTIS), which centralizes processes with the aim of speeding up these studies, is now operational Source: www.actasanitaria.com With the entry into force, this Monday, January 31, of the Clinical Trials Information System (CTIS), clinical trials in the European Union are going to undergo important changes for the benefit of […]

Seven out of ten drugs in clinical development are ‘first in class’.

A report on the research pipeline of global pharmaceutical companies highlights the importance of this ‘first-in-class’ share for patients with unmet medical needs. It captures notable advances in rare diseases, where it sees a regulatory framework that stimulates incentivised research as critical, and underlines the value of future breakthrough therapies based on precision medicine. Source: […]

“The pandemic has shown that more Autonomous Communities can host clinical trials of drugs, which is hopeful for many patients”

More than 50% of the trials with new treatments are currently concentrated in Madrid and Barcelona Spain, a benchmark in clinical research, should also bet on greater digitization in these studies to gain competitiveness, says the associate director of Clinical and Translational Research at Farmaindustria Source: www.farmaindustria.es Before the pandemic, Spain was already a world […]